Thrombosis with epsilon aminocaproic acid therapy.
D000328:Adult; D000614:Aminocaproates / Q000008:administration & dosage / Q000009:adverse effects*; D001663:Bilirubin / Q000097:blood; D001792:Blood Platelets; D001803:Blood Transfusion; D001806:Blood Urea Nitrogen; D002122:Calcium Chloride / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects; D006470:Hemorrhage / Q000188:drug therapy; D006801:Humans; D007678:Kidney Glomerulus / Q000187:drug effects / Q000473:pathology; D011183:Postoperative Complications; D011479:Protamines / Q000627:therapeutic use; D011517:Prothrombin Time; D013771:Tetralogy of Fallot / Q000601:surgery; D013917:Thrombin / Q000032:analysis; D013927:Thrombosis / Q000139:chemically induced* / Q000473:pathology
D000614:Aminocaproates; D011479:Protamines; D005340:Fibrinogen; D003404:Creatinine; D013917:Thrombin; D002122:Calcium Chloride; D001663:Bilirubin